Hair loss risk goes up on GLP-1 drugs, BMJ study finds
Sentiment Mix
Geography
Expert Signals
Global News - Main Feed
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
Hair loss risk goes up on GLP-1 drugs, BMJ study finds.
Supported by 1 story
The BMJ study examined over 50,000 people with Type 2 diabetes taking GLP-1 receptor stimulants, comparing them with patients using other diabetes drugs such as SGLT-2 and DPP-4.
Supported by 1 story
Related Events
An FDA Panel Just Endorsed These Unproven Peptides - WIRED
Uncategorized • 7/24/2026
Iran Update Special Report, July 23, 2026 - Institute for the Study of War
Research • 7/24/2026
Venice Chief Alberto Barbera on Hollywood’s Festival Retreat, Gender Parity Backslide and the AI Question - The Hollywood Reporter
Uncategorized • 7/24/2026
WestJet allowing passengers to change or cancel certain flights due to threat of strike - CBC
Security • 7/24/2026
SpaceX Is Turning Away Falcon Customers in Major Bet on Starship - Bloomberg.com
Uncategorized • 7/24/2026